tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Gregory Renza, 211 are a BUY (81.15%), 49 are a HOLD (18.85%).
Analyst Gregory Renza, currently employed at RBC, carries an average stock price target met ratio of 36.46% that have a potential upside of 28.75% achieved within 83 days.
Gregory Renza’s has documented 511 price targets and ratings displayed on 36 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CRMD, CorMedix at 26-Mar-2025.
Analyst best performing recommendations are on RXDX (PROMETHEUS BIOSCIENCES).
The best stock recommendation documented was for RXDX (PROMETHEUS BIOSCIENCES) at 12/7/2022. The price target of $111 was fulfilled within 1 day with a profit of $15.2 (15.87%) receiving and performance score of 158.66.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$20
$2.93 (17.16%)
$20
23 days ago
(07-Mar-2025)
16/21 (76.19%)
$2.39 (13.57%)
172
Buy
$27
$9.93 (58.17%)
$27
1 months 3 days ago
(27-Feb-2025)
7/21 (33.33%)
$7.66 (39.61%)
118
Buy
$28
$10.93 (64.03%)
$28
1 months 3 days ago
(27-Feb-2025)
0/6 (0%)
$8.66 (44.78%)
Buy
$28
$10.93 (64.03%)
$28
1 months 3 days ago
(27-Feb-2025)
25/37 (67.57%)
$8.66 (44.78%)
486
Hold
$22
$4.93 (28.88%)
$24
1 months 19 days ago
(11-Feb-2025)
16/21 (76.19%)
$3.51 (18.98%)
174
Which stock is Gregory Renza is most bullish on?
Which stock is Gregory Renza is most reserved on?
What Year was the first public recommendation made by Gregory Renza?
